AG
JAZZ icon

AmeriFlex Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

AmeriFlex Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$143K Buy
592
+43
+8% +$9.42K 0.06% 275
2026
Q1 		$104K Hold
549
– – 0.05% 269
2025
Q4 		$93.3K Buy
549
+545
+13,625% +$83.6K 0.05% 292
2025
Q3 		$527 Buy
+4
New +$480 ﹤0.01% 1035
2025
Q2 		– Sell
-549
Closed -$68.2K – 1181
2025
Q1 		$68.2K Buy
549
+547
+27,350% +$71.4K 0.03% 402
2024
Q4 		$249 Buy
+2
New +$236 ﹤0.01% 1137

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

AmeriFlex Group's JAZZ Position: Q2 2026 in Review

AmeriFlex Group increased its Jazz Pharmaceuticals (JAZZ) stake by 7.8% in Q2 2026, buying an estimated $9.42K and bringing the position to 592 shares worth $143K. The position accounts for 0.06% of the portfolio, ranked #275.

AmeriFlex Group first reported a position in JAZZ in Q4 2024 and has held it in 6 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • AmeriFlex Group held 592 shares of Jazz Pharmaceuticals worth $143K as of Q2 2026.
  • AmeriFlex Group bought 43 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.42K.
  • Jazz Pharmaceuticals made up 0.06% of AmeriFlex Group's portfolio in Q2 2026, its #275 holding.
  • AmeriFlex Group first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.